炎症信号在骨髓增生异常综合征发病机制中的核心作用
综述阐述骨髓增生异常综合征(MDS)中先天免疫异常激活与促炎信号是关键致病驱动因素,S100A9介导的NLRP3炎症小体激活及细胞焦亡参与疾病特征,体细胞突变可驱动该通路,NLRP3炎症小体激活可能作为MDS疾病特异性生物标志物并驱动年龄相关克隆性造血者的心血管疾病负担。
要点
- MDS中异常先天免疫激活和促炎信号是疾病的关键致病驱动因素。
- S100A9介导的NLRP3炎症小体激活驱动细胞焦亡,参与MDS多种标志性特征。
- NLRP3炎症小体激活可能是MDS的疾病特异性生物标志物,并驱动年龄相关克隆性造血者的心血管疾病负担。
核心结论
- 异常先天免疫激活在MDS中的机制作用为治疗开发提供了新视角,可能催生一类新的疾病修饰药物。
研究设计与样本
- 综述,检索范围原文未报告。
主要发现
- S100A9介导的NLRP3炎症小体激活驱动一种炎症性、裂解性细胞死亡形式即细胞焦亡,构成MDS许多标志性特征的基础。
- 该环路及其他危险相关分子模式的释放扩增骨髓髓源性抑制细胞,形成前馈过程传播炎症小体激活。
- 不同功能类别的体细胞基因突变使NLRP3炎症小体产生共同表型,包括活性氧生成过多、Wnt/β-catenin诱导的增殖、阳离子流诱导的细胞肿胀和caspase-1激活。
- 近期研究表明NLRP3炎症小体复合物激活具有更广泛的重要性,特别是作为MDS可能的疾病特异性生物标志物,以及作为年龄相关克隆性造血者心血管疾病负担的驱动因素。
关键数值与推荐
- 原文未报告。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In cancer biology, tumor-promoting inflammation and an inflammatory microenvironment play a vital role in disease pathogenesis. In the past decade, aberrant innate immune activation and proinflammatory signaling within the malignant clone and the bone marrow (BM) microenvironment were identified as key pathogenic drivers of myelodysplastic syndromes (MDS). In particular, S100A9-mediated NOD-like receptor protein 3 (NLRP3) inflammasome activation directs an inflammatory, lytic form of cell death termed pyroptosis that underlies many of the hallmark features of the disease. This circuit and accompanying release of other danger-associated molecular patterns expands BM myeloid-derived suppressor cells, creating a feed-forward process propagating inflammasome activation. Furthermore, somatic gene mutations of varied functional classes license the NLRP3 inflammasome to generate a common phenotype with excess reactive oxygen species generation, Wnt/β-catenin-induced proliferation, cation flux-induced cell swelling, and caspase-1 activation. Recent investigations have shown that activation of the NLRP3 inflammasome complex has more broad-reaching importance, particularly as a possible disease-specific biomarker for MDS, and, mechanistically, as a driver of cardiovascular morbidity/mortality in individuals with age-related, clonal hematopoiesis. Recognition of the mechanistic role of aberrant innate immune activation in MDS provides a new perspective for therapeutic development that could usher in a novel class of disease-modifying agents.
引用
- Sallman DA, List A. The central role of inflammatory signaling in the pathogenesis of myelodysplastic syndromes. Blood. 2019. PMID: 30670444. doi:10.1182/blood-2018-10-844654
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。